Evidence map›Paper›PMID 33451803›Full record

ReviewMolecular aspects of medicine2021

Nuclear receptors, the aryl hydrocarbon receptor, and macrophage function.

Sara Lamorte, Rahul Shinde, Tracy L McGaha

Open access · greenAbstract readReview
In one paragraph

Review in Molecular aspects of medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 36 citations in OpenAlex.

  1. Journal of agricultural and food chemistry · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Sara LamorteTumor Immunotherapy Program, The Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Rahul ShindeImmunology, Microenvironment and Metastasis Program, The Wistar Institute Cancer Center, Philadelphia, PA, USA.
Tracy L McGahaTumor Immunotherapy Program, The Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; The Department of Immunology, The University of Toronto, Toronto, ON, Canada. Electronic address: tmcgaha@uhnresearch.ca.
University Health Network · CAThe Wistar Institute · US

Funding

Mechanistic investigations of microbiome-driven aryl hydrocarbon receptor activity and macrophage function in pancreatic cancer.R01CA255670 · NCI · UNIVERSITY HEALTH NETWORK · PI MCGAHA, TRACY L · 2021 to 2025
$1.8M
The role of marginal zone macrophages and immuno-metabolism in tumor-driven MDSC developmentR01CA190449 · NCI · UNIVERSITY HEALTH NETWORK · PI MCGAHA, TRACY L · 2015 to 2020
$1.3M
Mechanistic relationships between IDO, GCN2, and mTOR signals in immunity to apoptotic cellsR01AR067763 · NIAMS · UNIVERSITY HEALTH NETWORK · PI MCGAHA, TRACY L · 2015 to 2019
$1.2M
The role of GCN2-kinase in antigen presenting cell function and tolerance to selfR21AI105500 · NIAID · AUGUSTA UNIVERSITY · PI MCGAHA, TRACY L · 2013 to 2014
$399k
CIHR 162114NCI NIH HHS R01 CA190449NCI NIH HHS R01 CA255670NIAID NIH HHS R21 AI105500NIAMS NIH HHS R01 AR067763
6 · The paper itself

Abstract

Nuclear receptors (NRs) are key regulators of innate immune responses and tissue homeostasis. Evidence indicates that NRs significantly impact steady-state immune regulation, uptake and processing of apoptotic cells, tolerance induction, and control of inflammatory immunity. In this review, we describe our current understanding of the NR activity for balancing inflammation and tolerance, the signaling cascade inducing the NR activation and functional responses, and different mechanisms of the NR-driven immune effects in the context of autoimmune diseases. We further describe the ligand-activated transcription factor the aryl hydrocarbon receptor (AhR) that exhibits analogous functionality. Moreover, we will discuss the putative role of NRs and AhR in immune regulation and disease pathogenesis providing a rationale for therapeutic targeting as a unique opportunities in the clinical management of autoimmune diseases.

Indexed as

MacrophagesReceptors, Aryl HydrocarbonGene Expression RegulationHumansImmunity, InnateInflammationReceptors, Aryl HydrocarbonAryl hydrocarbon receptorAutoimmunityEfferocytosisInflammationMacrophages

Identifiers

PMID33451803
PMCPMC7987878
OpenAlexW3120357032

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.